Recent Advances and Challenges in Stereotactic Body Radiotherapy.
作者信息
Katano Atsuto, Minamitani Masanari, Ohira Shingo, Yamashita Hideomi
机构信息
Department of Radiology, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Department of Comprehensive Radiation Oncology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
出版信息
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241229363. doi: 10.1177/15330338241229363.
Abstract
摘要
相似文献
1
Recent Advances and Challenges in Stereotactic Body Radiotherapy.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241229363. doi: 10.1177/15330338241229363.
2
A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818798633. doi: 10.1177/1533033818798633.
3
Salvage operation for late recurrence after stereotactic body radiotherapy for lung cancer: two patients with no viable cancer cells.
Ann Thorac Surg. 2014 Jun;97(6):2167-71. doi: 10.1016/j.athoracsur.2013.07.123.
4
Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report.
J Med Case Rep. 2017 Dec 10;11(1):343. doi: 10.1186/s13256-017-1504-z.
5
Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818783904. doi: 10.1177/1533033818783904.
6
Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.
J Thorac Cardiovasc Surg. 2017 Aug;154(2):689-699. doi: 10.1016/j.jtcvs.2017.03.142. Epub 2017 Apr 14.
7
Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
J Thorac Cardiovasc Surg. 2018 Jan;155(1):395-402. doi: 10.1016/j.jtcvs.2017.07.065. Epub 2017 Aug 16.
8
Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy.
Ann Thorac Surg. 2018 Apr;105(4):e165-e168. doi: 10.1016/j.athoracsur.2017.11.003.
9
The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?
Clin Lung Cancer. 2016 Sep;17(5):406-411. doi: 10.1016/j.cllc.2015.12.003. Epub 2015 Dec 18.
10
Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.
Jpn J Clin Oncol. 2016 Jul;46(7):687-91. doi: 10.1093/jjco/hyw047. Epub 2016 May 9.
引用本文的文献
1
Salvage Radiation Therapy for Localised Prostate Cancer Recurrence Following High-Intensity Focused Ultrasound (HIFU) Failure.
J Med Imaging Radiat Oncol. 2025 Sep;69(6):681-686. doi: 10.1111/1754-9485.70009. Epub 2025 Aug 15.
2
Volumetric and spatial changes in brain metastases during stereotactic radiosurgery: a case for off-line adaptive planning.
Clin Transl Radiat Oncol. 2025 Jun 24;54:101000. doi: 10.1016/j.ctro.2025.101000. eCollection 2025 Sep.
3
The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma.
Front Med (Lausanne). 2025 Jun 6;12:1576494. doi: 10.3389/fmed.2025.1576494. eCollection 2025.
4
Stereotactic Body Radiation Therapy for Oligometastatic Recurrent Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study From a Single Tertiary Center.
Cancer Rep (Hoboken). 2025 Jun;8(6):e70248. doi: 10.1002/cnr2.70248.
5
Exploring the Current Challenges and Pioneering Clinical Applications of Stereotactic Radiotherapy in Cancer Treatment.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251333658. doi: 10.1177/15330338251333658. Epub 2025 Apr 3.
6
Salvage Chemoradiotherapy for Loco-Regional Recurrence of Esophageal Squamous Cell Carcinoma After Esophagectomy.
J Clin Med. 2025 Feb 25;14(5):1540. doi: 10.3390/jcm14051540.
7
FLASH Radiotherapy: Benefits, Mechanisms, and Obstacles to Its Clinical Application.
Int J Mol Sci. 2024 Nov 21;25(23):12506. doi: 10.3390/ijms252312506.
8
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Child-Pugh Class C As Bridge Therapy Before Liver Transplantation.
Cureus. 2024 Oct 16;16(10):e71654. doi: 10.7759/cureus.71654. eCollection 2024 Oct.
9
Comparative analysis of clinical treatment outcomes: Breath-hold vs. free-breathing techniques in liver stereotactic body radiotherapy.
J Med Imaging Radiat Oncol. 2025 Feb;69(1):136-143. doi: 10.1111/1754-9485.13793. Epub 2024 Oct 20.
10
Stereotactic Ablative Radiation Therapy for Sacral Bone Metastasis in Recurrent Type A Thymoma: A Two-Year Follow-Up Demonstrating Pain Reduction and Local Control.
Cureus. 2024 Aug 18;16(8):e67142. doi: 10.7759/cureus.67142. eCollection 2024 Aug.
本文引用的文献
1
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet. 2023 Sep 9;402(10405):871-881. doi: 10.1016/S0140-6736(23)01384-3. Epub 2023 Jul 18.
2
Adaptive Radiation Therapy: A Review of CT-based Techniques.
Radiol Imaging Cancer. 2023 Jul;5(4):e230011. doi: 10.1148/rycan.230011.
3
Novel breath-hold liver target stereotactic ablative radiotherapy using the intrafraction diaphragm registration of kilovoltage projection streaming image with digitally reconstructed radiography of the planning computed tomography.
Tech Innov Patient Support Radiat Oncol. 2023 Jun 28;27:100217. doi: 10.1016/j.tipsro.2023.100217. eCollection 2023 Sep.
4
Image-mode performance characterisation of a positron emission tomography subsystem designed for Biology-guided radiotherapy (BgRT).
Br J Radiol. 2023 Jan 1;96(1141):20220387. doi: 10.1259/bjr.20220387. Epub 2022 Nov 15.
5
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13.
6
Establishment of a Prediction Model for Overall Survival after Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer Using Radiomics Analysis.
Cancers (Basel). 2022 Aug 10;14(16):3859. doi: 10.3390/cancers14163859.
7
Radiotherapy combined with immunotherapy: the dawn of cancer treatment.
Signal Transduct Target Ther. 2022 Jul 29;7(1):258. doi: 10.1038/s41392-022-01102-y.
8
Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy.
Biomedicines. 2022 Mar 3;10(3):597. doi: 10.3390/biomedicines10030597.
9
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.
Lancet Oncol. 2022 Mar;23(3):e105-e115. doi: 10.1016/S1470-2045(22)00066-3.
10
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Lancet Oncol. 2021 Jul;22(7):1023-1033. doi: 10.1016/S1470-2045(21)00196-0. Epub 2021 Jun 11.
Zotero 插件